Five weeks since listing, and still below issue price.
Seems like a good product, if their heart device is as good a device as Ventracor's, then one would think that SHC's market capitalisation would trend towards that of VCR's.
Lot's of upside potential, and I guess lot's of downside as well.
I hold, hoping for the upside!!
Regards,
TDF
anyone with views on shc?, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)